Acyclovir resistance in herpes simplex virus type I encephalitis: a case report

被引:0
作者
M. Bergmann
R. Beer
M. Kofler
R. Helbok
B. Pfausler
E. Schmutzhard
机构
[1] Medical University Innsbruck,Department of Neurology, Neurocritical Care Unit
来源
Journal of NeuroVirology | 2017年 / 23卷
关键词
Acyclovir resistance; Herpes simplex virus type I; Encephalitis; Foscarnet;
D O I
暂无
中图分类号
学科分类号
摘要
Acyclovir resistance is rarely seen in herpes simplex virus (HSV) type I encephalitis. Prevalence rates vary between 0.5 % in immunocompetent patients (Christophers et al. 1998; Fife et al. 1994) and 3.5–10 % in immunocompromised patients (Stranska et al. 2005). We report a 45-year-old, immunocompetent (negative HIV antigen/antibody testing), female patient, without previous illness who developed—after a febrile prodromal stage—aphasia and psychomotor slowing. Cerebral magnetic resonance imaging (cMRI) showed right temporal and insular T2-hyperintense lesions with spreading to the contralateral temporal lobe. Cerebrospinal fluid (CSF) analysis yielded lymphocytic pleocytosis and elevated protein level. Polymerase chain reaction testing for HSV type I showed a positive result in repeat lumbar puncture. HSV type I encephalitis was diagnosed and intravenous acyclovir treatment was initiated (750 mg t.i.d.). Acyclovir treatment was intensified to 1000 mg t.i.d., due to clinical deterioration, ongoing pleocytosis and progression on cMRI 5 days after initiation of antiviral therapy. In parallel, acyclovir resistance testing showed mutation of thymidine kinase gene at position A156V prompting foscarnet therapy (60 mg t.i.d.). Patient’s condition improved dramatically over 2 weeks. Acyclovir resistance is rare but should be considered in case of clinical worsening of patient’s condition. To our knowledge, this is the first report of acyclovir resistance in HSV type I encephalitis of an immunocompetent and previously healthy patient in Austria.
引用
收藏
页码:335 / 337
页数:2
相关论文
共 110 条
  • [1] Andrei G(2013)Herpes simplex virus drug-resistance: new mutations and insights Curr Opin Infect Dis 26 551-560
  • [2] Snoeck R(1982)Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy Lancet 1 421-423
  • [3] Burns WH(1998)Survey of resistance of herpes simplex virus to acyclovir in northwest England Antimicrob Agents Chemother 42 868-872
  • [4] Saral R(1982)Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir N Engl J Med 306 343-346
  • [5] Santos GW(2004)Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up J Clin Microbiol 42 242-249
  • [6] Laskin OL(1994)Recurrence and resistance patterns of herpes simplex virus following cessation of > or =6 years of chronic suppression with acyclovir. Acyclovir Study Group J Infect Dis 169 1338-1341
  • [7] Lietman PS(1990)Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS J Infect Dis 161 711-715
  • [8] McLaren C(2009)Incidence and temporal trends of primary immunodeficiency: a population-based cohort study Mayo Clin Proc 84 16-22
  • [9] Barry DW(2004)HSV excretion after bone marrow transplantation: a 4-year survey J Clin Virol 30 341-345
  • [10] Christophers J(2011)Resistence of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management Antimicrob Agents Chemother 55 459-472